Marico to acquire 58% stake in Satiya Nutraceuticals for Rs 369 crore
It has completed acquisition of 32.75 per cent of the paid-up share capital of Satiya Nutraceuticals through primary infusion and secondary buyouts, completed on July 26, 2023.

According to Marico this is in line with its key strategic priorities.
Marico to acquire 58 pc stake in Satiya Nutraceuticals for Rs 369 cr
It has completed acquisition of 32.75 per cent of the paid-up share capital of Satiya Nutraceuticals through primary infusion and secondary buyouts, completed on July 26, 2023.
It will acquire the remaining 25.25 per cent of the paid-up share capital of Satiya Nutraceuticals on a fully-diluted basis, in one or more tranches by May 2025, said Marico.
"In line with our strategy to accelerate our diversification journey, the investment in Plix not only expands our total addressable market in value-added wellness foods and nutrition segments, but also brings another digital first brand with a distinct value proposition into our fold," said Saugata Gupta, MD and CEO, Marico.
"In partnership with Marico, we will prioritize strengthening the brand's equity and expedite growth by expanding into new categories and channels.
"In addition to leveraging Marico's core competencies, we foresee compelling synergies that align with our brand's aspirations, thereby signifying a fruitful strategic partnership in the years ahead," said Rishubh Satiya & Akash Zaveri, Co-founders of Plix.
For the financial year that ended on March 31, 2023, consolidated turnover of Satiya Nutraceuticals was at Rs 106.43 crore.
Download ET Markets APP